263 related articles for article (PubMed ID: 18452536)
1. The molecular and cellular basis of exostosis formation in hereditary multiple exostoses.
Trebicz-Geffen M; Robinson D; Evron Z; Glaser T; Fridkin M; Kollander Y; Vlodavsky I; Ilan N; Law KF; Cheah KS; Chan D; Werner H; Nevo Z
Int J Exp Pathol; 2008 Oct; 89(5):321-31. PubMed ID: 18452536
[TBL] [Abstract][Full Text] [Related]
2. Heparan sulfate abnormalities in exostosis growth plates.
Hecht JT; Hall CR; Snuggs M; Hayes E; Haynes R; Cole WG
Bone; 2002 Jul; 31(1):199-204. PubMed ID: 12110435
[TBL] [Abstract][Full Text] [Related]
3. Differentiation-induced loss of heparan sulfate in human exostosis derived chondrocytes.
Hecht JT; Hayes E; Haynes R; Cole WG; Long RJ; Farach-Carson MC; Carson DD
Differentiation; 2005 Jun; 73(5):212-21. PubMed ID: 16026543
[TBL] [Abstract][Full Text] [Related]
4. Cytoskeletal abnormalities in chondrocytes with EXT1 and EXT2 mutations.
Bernard MA; Hogue DA; Cole WG; Sanford T; Snuggs MB; Montufar-Solis D; Duke PJ; Carson DD; Scott A; Van Winkle WB; Hecht JT
J Bone Miner Res; 2000 Mar; 15(3):442-50. PubMed ID: 10750558
[TBL] [Abstract][Full Text] [Related]
5. Diminished levels of the putative tumor suppressor proteins EXT1 and EXT2 in exostosis chondrocytes.
Bernard MA; Hall CE; Hogue DA; Cole WG; Scott A; Snuggs MB; Clines GA; Lüdecke HJ; Lovett M; Van Winkle WB; Hecht JT
Cell Motil Cytoskeleton; 2001 Feb; 48(2):149-62. PubMed ID: 11169766
[TBL] [Abstract][Full Text] [Related]
6. Reevaluation of a genetic model for the development of exostosis in hereditary multiple exostosis.
Hall CR; Cole WG; Haynes R; Hecht JT
Am J Med Genet; 2002 Sep; 112(1):1-5. PubMed ID: 12239711
[TBL] [Abstract][Full Text] [Related]
7. EXT 1 gene mutation induces chondrocyte cytoskeletal abnormalities and defective collagen expression in the exostoses.
Legeai-Mallet L; Rossi A; Benoist-Lasselin C; Piazza R; Mallet JF; Delezoide AL; Munnich A; Bonaventure J; Zylberberg L
J Bone Miner Res; 2000 Aug; 15(8):1489-500. PubMed ID: 10934647
[TBL] [Abstract][Full Text] [Related]
8. Glycosaminoglycans in the blood of hereditary multiple exostoses patients: Half reduction of heparan sulfate to chondroitin sulfate ratio and the possible diagnostic application.
Anower-E-Khuda MF; Matsumoto K; Habuchi H; Morita H; Yokochi T; Shimizu K; Kimata K
Glycobiology; 2013 Jul; 23(7):865-76. PubMed ID: 23514715
[TBL] [Abstract][Full Text] [Related]
9. Three novel EXT1 and EXT2 gene mutations in Taiwanese patients with multiple exostoses.
Chen WC; Chi CH; Chuang CC; Jou IM
J Formos Med Assoc; 2006 May; 105(5):434-7. PubMed ID: 16638657
[TBL] [Abstract][Full Text] [Related]
10. The pathogenic roles of heparan sulfate deficiency in hereditary multiple exostoses.
Pacifici M
Matrix Biol; 2018 Oct; 71-72():28-39. PubMed ID: 29277722
[TBL] [Abstract][Full Text] [Related]
11. No haploinsufficiency but loss of heterozygosity for EXT in multiple osteochondromas.
Reijnders CM; Waaijer CJ; Hamilton A; Buddingh EP; Dijkstra SP; Ham J; Bakker E; Szuhai K; Karperien M; Hogendoorn PC; Stringer SE; Bovée JV
Am J Pathol; 2010 Oct; 177(4):1946-57. PubMed ID: 20813973
[TBL] [Abstract][Full Text] [Related]
12. Heparanase stimulates chondrogenesis and is up-regulated in human ectopic cartilage: a mechanism possibly involved in hereditary multiple exostoses.
Huegel J; Enomoto-Iwamoto M; Sgariglia F; Koyama E; Pacifici M
Am J Pathol; 2015 Jun; 185(6):1676-85. PubMed ID: 25863260
[TBL] [Abstract][Full Text] [Related]
13. A splice mutation and mRNA decay of EXT2 provoke hereditary multiple exostoses.
Tian C; Yan R; Wen S; Li X; Li T; Cai Z; Li X; Du H; Chen H
PLoS One; 2014; 9(4):e94848. PubMed ID: 24728384
[TBL] [Abstract][Full Text] [Related]
14. Osteochondroma formation is independent of heparanase expression as revealed in a mouse model of hereditary multiple exostoses.
Mundy C; Chung J; Koyama E; Bunting S; Mahimkar R; Pacifici M
J Orthop Res; 2022 Oct; 40(10):2391-2401. PubMed ID: 34996123
[TBL] [Abstract][Full Text] [Related]
15. Novel mutation in the EXT-1 gene in an Iranian family affected with hereditary multiple exostoses.
Foroughmand AM; Galehdari H; Rasouli M; Mohammadian G; Mohammadi M
Pak J Biol Sci; 2008 Apr; 11(7):1037-41. PubMed ID: 18810975
[TBL] [Abstract][Full Text] [Related]
16. Heparan sulfate in skeletal development, growth, and pathology: the case of hereditary multiple exostoses.
Huegel J; Sgariglia F; Enomoto-Iwamoto M; Koyama E; Dormans JP; Pacifici M
Dev Dyn; 2013 Sep; 242(9):1021-32. PubMed ID: 23821404
[TBL] [Abstract][Full Text] [Related]
17. A novel EXT1 splice site mutation in a kindred with hereditary multiple exostosis and osteoporosis.
Lemos MC; Kotanko P; Christie PT; Harding B; Javor T; Smith C; Eastell R; Thakker RV
J Clin Endocrinol Metab; 2005 Sep; 90(9):5386-92. PubMed ID: 15985493
[TBL] [Abstract][Full Text] [Related]
18. The type 2 diabetes associated rs7903146 T allele within TCF7L2 is significantly under-represented in Hereditary Multiple Exostoses: insights into pathogenesis.
Sgariglia F; Pedrini E; Bradfield JP; Bhatti TR; D'Adamo P; Dormans JP; Gunawardena AT; Hakonarson H; Hecht JT; Sangiorgi L; Pacifici M; Enomoto-Iwamoto M; Grant SF
Bone; 2015 Mar; 72():123-7. PubMed ID: 25498973
[TBL] [Abstract][Full Text] [Related]
19. A novel splice mutation induces exon skipping of the EXT1 gene in patients with hereditary multiple exostoses.
Guo X; Lin M; Yan W; Chen W; Hong G
Int J Oncol; 2019 Mar; 54(3):859-868. PubMed ID: 30664192
[TBL] [Abstract][Full Text] [Related]
20. Novel EXT1 mutation identified in a pedigree with hereditary multiple exostoses.
Cao L; Liu F; Kong M; Fang Y; Gu H; Chen Y; Zhao C; Zhang S; Bi Q
Oncol Rep; 2014 Feb; 31(2):713-8. PubMed ID: 24297320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
